Nika Pharmaceuticals, Inc (NIKA) — 10-Q Filings

10-Q Filings (6)

• NIKA Pharmaceuticals Reports Zero Revenue, Narrows Q3 Loss Amidst Going Concern Doubts — Nov 7, 2025 Risk: high
  NIKA PHARMACEUTICALS, INC. (NIKA) reported no revenue for the three and nine months ended September 30, 2025, continuing its trend of zero revenue from the prio
• NIKA Pharmaceuticals Narrows Losses Amidst Zero Revenue, Going Concern Doubts Persist — Aug 14, 2025 Risk: high
  NIKA PHARMACEUTICALS, INC. reported a net loss of $18,381 for the three months ended June 30, 2025, an improvement from the $22,457 net loss in the same period
• Nika Pharmaceuticals Files Q1 2025 10-Q — May 13, 2025 Risk: low
  Nika Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company, previously known as Centennial Growth Equi
• Nika Pharmaceuticals Files Q3 2024 10-Q — Nov 12, 2024 Risk: low
  Nika Pharmaceuticals, Inc. filed its Form 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and position as
• Nika Pharmaceuticals Files Q2 2024 10-Q — Sep 18, 2024 Risk: low
  Nika Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly Centennial Growth Equities Inc., is based in Henderson, NV.
• Nika Pharmaceuticals Files Q1 2024 10-Q — May 28, 2024 Risk: low
  Nika Pharmaceuticals, Inc. filed its quarterly report for the period ending March 31, 2024. The company, formerly Centennial Growth Equities Inc., is based in H

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX